Ability To Culture Rare Tumor Cells Isolated From Blood Could Help Improve Patient Response To Therapy

A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children's Hospital Boston has created a microfluidic device that can harvest rare circulating tumor cells (CTCs) from blood to enable their expansion in culture for analysis. These cells, which have detached from a primary cancer site and often create a secondary -- or metastasized -- tumor, hold an extraordinary amount of information regarding patient-specific drug sensitivity, cancer progression, and patient response to therapy...

Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/XwXIYzwc3bQ/244577.php

sport medical sport news news